Faculty of Medicine and Health, Central Clinical School, Sydney, NSW, Australia.
Nutrition and Dietetics Department, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
J Hum Nutr Diet. 2023 Oct;36(5):1741-1750. doi: 10.1111/jhn.13225. Epub 2023 Sep 1.
Home parenteral nutrition (HPN) is a specialised therapy offered to people suffering from intestinal failure. Underlying disease, HPN complications and limitations of HPN can significantly impact a person's quality-of-life (QOL). The aim of this review was to evaluate the evidence on existing non-surgical/non-pharmacological interventions aimed at improving QOL, clinical, patient-reported and economic outcomes for patients receiving parenteral nutrition therapy at home across adult and paediatric settings.
Online databases Medline (Ovid), Embase and Cinahl were searched to identify studies published between 1937 and 31 March 2022. Identified studies were appraised using the Cochrane Collaboration risk of bias tool and Grading of Recommendations Assessment, Development and Evaluation (GRADE) assessment.
Nine studies were included in this review. Interventions were focused on education (n = 4), telemedicine (n = 2), preparation of infusion mixtures (n = 1), mindfulness-based cognitive therapy (n = 1) and a multi-modal approach (n = 1). Only one study measured QOL before and after the intervention using a validated QOL tool. All studies were assessed at either some, high or critical risk of bias, resulting in low or very low-quality evidence for the interventions evaluated.
The findings from this review highlight the lack of high-quality non-surgical/non-pharmacological studies seeking to improve QOL for people on HPN. Because the majority of people receiving HPN are not eligible for surgical or pharmaceutical treatments, higher quality research using clinical trial design, and research focused on improving QOL is needed to inform healthcare managers about the effectiveness (and value) of alternative service delivery models for this vulnerable patient group.
家庭肠外营养(HPN)是为患有肠衰竭的人提供的一种专门治疗方法。基础疾病、HPN 并发症和 HPN 的局限性会严重影响患者的生活质量(QOL)。本综述的目的是评估现有的非手术/非药物干预措施的证据,这些措施旨在改善接受家庭肠外营养治疗的患者的 QOL、临床、患者报告和经济结果,包括成人和儿科患者。
在线数据库 Medline(Ovid)、Embase 和 Cinahl 被检索以确定在 1937 年至 2022 年 3 月 31 日期间发表的研究。使用 Cochrane 协作风险偏倚工具和 Grading of Recommendations Assessment, Development and Evaluation(GRADE)评估对确定的研究进行评估。
本综述共纳入了 9 项研究。干预措施主要集中在教育(n=4)、远程医疗(n=2)、输注混合物的制备(n=1)、正念认知疗法(n=1)和多模式方法(n=1)。只有一项研究使用经过验证的 QOL 工具在干预前后测量了 QOL。所有研究均被评估为存在一定程度、高风险或关键风险的偏倚,导致评估的干预措施的证据质量为低或极低。
本综述的结果强调了缺乏高质量的非手术/非药物研究,旨在提高接受 HPN 治疗的患者的生活质量。由于大多数接受 HPN 的患者不符合手术或药物治疗的条件,因此需要使用临床试验设计和专注于提高 QOL 的研究来为医疗保健管理者提供有关为这一脆弱患者群体提供替代服务交付模式的有效性(和价值)的信息。